Bitterman PB - Search Results

1

Characterization of the lower respiratory tract inflammation of nonsmoking individuals with interstitial lung disease associated with chronic inhalation of inorganic dusts.

Rom WN, Bitterman PB, Rennard SI, Cantin A, Crystal RG. Rom WN, et al. Among authors: bitterman pb. Am Rev Respir Dis. 1987 Dec;136(6):1429-34. doi: 10.1164/ajrccm/136.6.1429. Am Rev Respir Dis. 1987. PMID: 2825569

2

Colchicine suppresses the release of fibroblast growth factors from alveolar macrophages in vitro. The basis of a possible therapeutic approach ot the fibrotic disorders.

Rennard SI, Bitterman PB, Ozaki T, Rom WN, Crystal RG. Rennard SI, et al. Among authors: bitterman pb. Am Rev Respir Dis. 1988 Jan;137(1):181-5. doi: 10.1164/ajrccm/137.1.181. Am Rev Respir Dis. 1988. PMID: 3337460

3

Evidence for chronic inflammation as a component of the interstitial lung disease associated with progressive systemic sclerosis.

Rossi GA, Bitterman PB, Rennard SI, Ferrans VJ, Crystal RG. Rossi GA, et al. Among authors: bitterman pb. Am Rev Respir Dis. 1985 Apr;131(4):612-7. doi: 10.1164/arrd.1985.131.4.612. Am Rev Respir Dis. 1985. PMID: 3994157

4

Alveolar macrophages in idiopathic pulmonary fibrosis have glucocorticoid receptors, but glucocorticoid therapy does not suppress alveolar macrophage release of fibronectin and alveolar macrophage derived growth factor.

Lacronique JG, Rennard SI, Bitterman PB, Ozaki T, Crystal RG. Lacronique JG, et al. Among authors: bitterman pb. Am Rev Respir Dis. 1984 Sep;130(3):450-6. doi: 10.1164/arrd.1984.130.3.450. Am Rev Respir Dis. 1984. PMID: 6476595

5

Modulation of alveolar macrophage-driven fibroblast proliferation by alternative macrophage mediators.

Bitterman PB, Wewers MD, Rennard SI, Adelberg S, Crystal RG. Bitterman PB, et al. J Clin Invest. 1986 Mar;77(3):700-8. doi: 10.1172/JCI112364. J Clin Invest. 1986. PMID: 3081573 Free PMC article.

6

The lung matrix and inflammation: Part II. Biochemical and molecular mechanisms of fibrogenesis: implications for environmental lung disease.

Brody AR, Bitterman PB, Adler KB, Rannels DE, Thet LA, Rom WN, Rennard SI. Brody AR, et al. Among authors: bitterman pb. Am Rev Respir Dis. 1988 Oct;138(4):1056-7. Am Rev Respir Dis. 1988. PMID: 3202435 No abstract available.

7

Familial idiopathic pulmonary fibrosis. Evidence of lung inflammation in unaffected family members.

Bitterman PB, Rennard SI, Keogh BA, Wewers MD, Adelberg S, Crystal RG. Bitterman PB, et al. N Engl J Med. 1986 May 22;314(21):1343-7. doi: 10.1056/NEJM198605223142103. N Engl J Med. 1986. PMID: 3702942

8

Response of the lower respiratory tract to injury. Mechanisms of repair of the parenchymal cells of the alveolar wall.

Rennard SI, Bitterman PB, Crystal RG. Rennard SI, et al. Among authors: bitterman pb. Chest. 1983 Dec;84(6):735-9. doi: 10.1378/chest.84.6.735. Chest. 1983. PMID: 6357653 Review.

9

Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract (first of two parts).

Crystal RG, Bitterman PB, Rennard SI, Hance AJ, Keogh BA. Crystal RG, et al. Among authors: bitterman pb. N Engl J Med. 1984 Jan 19;310(3):154-66. doi: 10.1056/NEJM198401193100304. N Engl J Med. 1984. PMID: 6361560 Review. No abstract available.

10

Pathogenesis of the granulomatous lung diseases.

Hunninghake GW, Garrett KC, Richerson HB, Fantone JC, Ward PA, Rennard SI, Bitterman PB, Crystal RG. Hunninghake GW, et al. Among authors: bitterman pb. Am Rev Respir Dis. 1984 Sep;130(3):476-96. doi: 10.1164/arrd.1984.130.3.476. Am Rev Respir Dis. 1984. PMID: 6433761 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

150 results

Search Page

Filters